Samsung Bioepis

Samsung Bioepis Co., Ltd. was founded in 2012 as a biopharmaceutical company dedicated to making healthcare accessible to all. Through innovative product development and an unwavering commitment to quality, Samsung Bioepis aims to become a world-leading biopharmaceutical company. Samsung Bioepis has launched a portfolio of 13 biosimilar products. The company continues to advance a broad pipeline of biosimilar candidates across a range of therapeutic areas, including immunology, oncology, and ophthalmology.